Loading company…
Los Altos-based biopharmaceutical company developing therapies for mitochondrial diseases and dysfunction.
Founded in 2006 and headquartered in Los Altos, US, Retrotope Inc. develops therapies for mitochondrial diseases and dysfunction. Its founder is Mikhail Shchepinov. The company has engaged in 15 deals since its inception. Its most recent funding was a Series D round in May 2021 raising USD 12.20 mn, with a current valuation of USD 168.266 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in